Oral Bioavailability

Low aqueous solubility resulting in poor oral bioavailability of drug candidates is an increasingly common challenge for the pharmaceutical industry. An estimated 60% to 70% of compounds in early development have poor bioavailability due to low solubility, representing a significant loss in economic and therapeutic opportunity. Capsugel Dosage Form Solutions has developed a patented delivery platform based on spray-dried dispersions (SDDs), which is available for license.

Topics: 
Bioavailability Enhancement